Document Detail


Safety and efficacy of meloxicam 7.5 mg in the treatment of osteoarthritis in Thai patients.
MedLine Citation:
PMID:  11853278     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A prospective, open trial to evaluate the safety and efficacy of oral meloxicam 7.5 mg once daily over a period of 28 days in Thai patients with osteoarthritis was conducted in 3 major hospitals in Bangkok, Thailand. A total of 137 patients were enrolled and completed the study protocol. The mean age of the patients was 57.6 years and 88 per cent were female. Pain on movement and pain at rest evaluated after treatment by visual analog scale (VAS) were significantly improved with respect to the baseline status (p<0.001). The final efficacy was reported as satisfactory or good in 97 per cent and 94 per cent as determined by patients and physicians respectively. Patient status evaluated at the end of the study reported improvement of their arthritic condition in 84 per cent. Drug tolerability assessed by patients and physicians and was good or satisfactory in 99 per cent and 98 per cent. GI adverse event was reported in 8.8 per cent. Other adverse events were itching/rash in 2.0 per cent and headache/insomnia in 1.5 per cent of patients. No patients withdrew from the study due to adverse events. No GI bleeding or perforation were observed. No hospitalization was observed during the study. There was no significant change of blood chemistry and hematological profile between pre and post treatment examination. Results from this study suggest that oral meloxicam 7.5 mg for 28 days is a safe and effective treatment regimen with high GI tolerability profile for the treatment of osteoarthritis in Thai patients.
Authors:
N Bunyaratavej; S Keorochana; S Pithkul
Related Documents :
9640718 - Trans-telephonic electrocardiographic monitoring--experience in india.
8689168 - Incidence of third-degree perineal tears in labour and outcome after primary repair.
6717508 - Physicians' reasons for not entering eligible patients in a randomized clinical trial o...
20081178 - Comparison of four treatments to suppress ovarian activity in ferrets (mustela putorius...
23184388 - Methods in measuring return to work: a comparison of measures of return to work followi...
23304968 - Occlusal bite force changes during 6 months of orthodontic treatment with fixed applian...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study    
Journal Detail:
Title:  Journal of the Medical Association of Thailand = Chotmaihet thangphaet     Volume:  84 Suppl 2     ISSN:  0125-2208     ISO Abbreviation:  J Med Assoc Thai     Publication Date:  2001 Oct 
Date Detail:
Created Date:  2002-02-20     Completed Date:  2002-03-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7507216     Medline TA:  J Med Assoc Thai     Country:  Thailand    
Other Details:
Languages:  eng     Pagination:  S542-6     Citation Subset:  IM    
Affiliation:
Department of Orthopaedic Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents, Non-Steroidal / adverse effects,  therapeutic use*
Female
Humans
Male
Middle Aged
Osteoarthritis / drug therapy*
Pain Measurement
Prospective Studies
Thiazines / adverse effects,  therapeutic use*
Thiazoles / adverse effects,  therapeutic use*
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Thiazines; 0/Thiazoles; 71125-38-7/meloxicam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of hypovitaminosis D in elderly women living in urban area of Khon Kaen province, Thailan...
Next Document:  Analysis of polymorphism of the interleukin-6 gene in Thai subjects with osteoporosis.